Engineered T cell-receptor based therapy of pancreatic ductal adenocarcinoma

被引：0

作者：

Stromnes, Ingunn M. ^{[1
]}

Schmitt, Thomas M. ^{[1
]}

Brockenbrough, Scott J. ^{[1
]}

Nguyen, Hieu ^{[1
]}

Cuevas, Carlos ^{[2
]}

Hulbert, Ayaka ^{[1
]}

Hotes, Jennifer ^{[1
]}

Dotson, Ashley ^{[1
]}

Hingorani, Sunil R. ^{[1
]}

Greenberg, Philip D. ^{[1
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

[2] Univ Washington, Seattle, WA 98195 USA

来源：

CANCER IMMUNOLOGY RESEARCH | 2016年 / 4卷 / 01期

关键词：

D O I：

10.1158/2326-6074.CRICIMTEATIAACR15-IA38

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

IA38

引用

页数：1

共 50 条

[21] The enhanced cell cycle related to the response to adjuvant therapy in pancreatic ductal adenocarcinoma
Mao, Yize
Cheng, Weisheng
Yang, Qiuxia
Li, Liqin
Hu, Wanming
Shuang, Zeyu
Fan, Dejun
Jiang, Xinlei
Gao, Feng
Li, Shengping
Wang, Wei
GENOMICS, 2022, 114 (01) : 95 - 106
[22] Growth Hormone Receptor: An Oncotarget for Pancreatic Ductal Adenocarcinoma
Subramani, Ramadevi
Lopez, Rebecca
Boopalan, Thiyagarajan
Arumugam, Arunkumar
Nandy, Sushmita B.
Lakshmanaswamy, Rajkumar
ENDOCRINE REVIEWS, 2014, 35 (03)
[23] Prolactin Receptor, a Novel Target for Pancreatic Ductal Adenocarcinoma
Dandawate, P.
Kaushik, G.
Subramaniam, D.
Ghosh, C.
Choudhury, S.
Standing, D.
Ramamoorthy, P.
Manzardo, A.
Sayed, A.
Banerjee, T.
Santra, S.
Butler, M.
Padhye, S. B.
Baranda, J.
Kasi, A.
Sun, W.
Tawfik, O.
Coppola, D.
Malafa, M.
Umar, S.
Soares, M. J.
Saha, S.
Weir, S. J.
Dhar, A.
Jensen, R. A.
Thomas, S. M.
Anant, S.
PANCREAS, 2018, 47 (10) : 1382 - 1382
[24] Research progress and design optimization of CAR-T therapy for pancreatic ductal adenocarcinoma
Li, Tianjiao
Li, Hao
Li, Shuo
Xu, Shuaishuai
Zhang, Wuhu
Gao, Heli
Xu, Huaxiang
Wu, Chuntao
Wang, Wenquan
Yu, Xianjun
Liu, Liang
CANCER MEDICINE, 2019, 8 (11): : 5223 - 5231
[25] Patient Preferences for Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
Hamad, Ahmad
Crossnohere, Norah
Ejaz, Aslam
Tsung, Allan
Pawlik, Timothy M.
Sarna, Angela
Santry, Heena
Wills, Celia
Cloyd, Jordan M.
PANCREAS, 2022, 51 (06) : 657 - 662
[26] Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
Qian, Yunzhen
Gong, Yitao
Fan, Zhiyao
Luo, Guopei
Huang, Qiuyi
Deng, Shengming
Cheng, He
Jin, Kaizhou
Ni, Quanxing
Yu, Xianjun
Liu, Chen
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
[27] Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A Collisson
Anguraj Sadanandam
Peter Olson
William J Gibb
Morgan Truitt
Shenda Gu
Janine Cooc
Jennifer Weinkle
Grace E Kim
Lakshmi Jakkula
Heidi S Feiler
Andrew H Ko
Adam B Olshen
Kathleen L Danenberg
Margaret A Tempero
Paul T Spellman
Douglas Hanahan
Joe W Gray
Nature Medicine, 2011, 17 : 500 - 503
[28] Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy
Zhang, Yi-Fan
Jiang, Shu-Heng
Hu, Li-Peng
Huang, Pei-Qi
Wang, Xu
Li, Jun
Zhang, Xue-Li
Nie, Hui-Zhen
Zhang, Zhi-Gang
CHINESE CLINICAL ONCOLOGY, 2019, 8 (02)
[29] Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Collisson, Eric A.
Sadanandam, Anguraj
Olson, Peter
Gibb, William J.
Truitt, Morgan
Gu, Shenda
Cooc, Janine
Weinkle, Jennifer
Kim, Grace E.
Jakkula, Lakshmi
Feiler, Heidi S.
Ko, Andrew H.
Olshen, Adam B.
Danenberg, Kathleen L.
Tempero, Margaret A.
Spellman, Paul T.
Hanahan, Douglas
Gray, Joe W.
NATURE MEDICINE, 2011, 17 (04) : 500 - U140
[30] Trends in the utilization of neoadjuvant therapy for pancreatic ductal adenocarcinoma
Brown, Zachary J.
Cloyd, Jordan M.
JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (06) : 1432 - 1440

← 1 2 3 4 5 →